The defective migration of Itk-/- CD8+ and CD4+ T cells likely contributes to the attenuation of GVHD, since these T cells continue to display GVL effects against leukemia cells that were injected intravenously and reside in secondary lymphoid organs. This evidence concerns the gene CD8A and leukemia.